Bioventix PLC
BVXP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £144 | £166 | £228 | £228 |
| - Cash | £5 | £5 | £6 | £6 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £139 | £161 | £222 | £222 |
| Revenue | £6 | £7 | £7 | £7 |
| % Growth | -5.2% | -2.9% | 3.8% | – |
| Gross Profit | £6 | £6 | £6 | £6 |
| % Margin | 92.6% | 87.8% | 92.4% | 93.2% |
| EBITDA | £5 | £5 | £5 | £5 |
| % Margin | 77.6% | 73.4% | 78% | 78.2% |
| Net Income | £4 | £4 | £4 | £4 |
| % Margin | 59.7% | 56% | 58.8% | 60.3% |
| EPS Diluted | 0.72 | 0.71 | 0.78 | 0.76 |
| % Growth | 1.4% | -9% | 2.6% | – |
| Operating Cash Flow | £4 | £4 | £4 | £4 |
| Capital Expenditures | £0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £4 | £4 | £4 | £4 |